Category

General

General

Future Labs & Future Production Solutions for the Pharma & Healthcare Industry

In today’s pharmaceutical and healthcare landscape, speed, compliance, and flexibility are critical success factors. Traditional facility projects are costly, complex, and slow — making it difficult for organizations to respond to market needs, scale capacity, or integrate new technologies quickly. To address this, CopperTec and J&K Consulting GmbH have created a new class of deployable infrastructure: Mobile Business Units (MBUs) serving as Future Labs and Future Production Solutions. These units deliver fully functional, GMP‑compliant, transportable laboratory and production environments — available wherever and whenever they are needed. Industry…
13. February 2026
General

Partnership with Delic Labs

Delic Labs is a Canadian company based in Vancouver with a focus on chemical process development, analytical testing, and extraction optimization. The company was initially founded in 2018 by Dr. Markus Roggen and Prof. Dr. Glenn Sammis and rebranded after being sold to the DELIC Group. Since its inception, the company has focused on improving the cannabis and psilocybin industry through collaborative research and fundamental science. For more information on Delic Labs, click here. Download the article as PDF here.…
20. January 2023
General

Partnership with Lindner Group

The Lindner Group is one of the leading companies worldwide for the building envelope, interior fit-out and insulation. Its comprehensive range of disciplines as a full-service provider for nearly all applications is unique.  Lindner SE | Clean Rooms is an internationally established full-service contractor for clean rooms, laboratories and operating theatres. We realise projects in the areas of pharmaceutical, sterile and hospital environment (ICUs, OTs etc.), microelectronics and semiconductor production around the world.  With this new partnership, we bring together…
27. October 2022
General

Partnership with ZEE – Zero Emission Energy

We are very pleased to announce another new partnership with ZEE GmbH. ZEE GmbH is a German provider of zero-emission energy systems that can be used to generate electrical and thermal green energy from agricultural by-products. ZEE stands for an efficient, clean, versatile and robust solution with a fast ROI and long lifetime. With this new partnership, we bring together an innovative manufacturer and the cGxP experts - and our customers benefit from a well-rounded service portfolio. For more information…
6. October 2022
CannabisGeneral

Partnership with DEVEX

We proudly announce our new partnership with DEVEX Verfahrenstechnik GmbH, who is a global provider of process engineering equipment, especially for the food and pharma industry. With over 20+ years of experience in the extraction business, DEVEX is a reliable partner for the cannabis/hemp industry. With this new partnership, we bring together the experienced plant manufacturer and the cGxP experts and our clients benefit from a well-rounded service portfolio. Get more information about DEVEX here. Download the article as PDF…
13. August 2022
General

Medicinal Cannabis – A matter of quality

from von Rainer Krüger und Dr. Lisann Eßer, J&K Consulting High demand and supposedly large profits are bringing more and more manufacturers of cannabis medicines onto the market. But can the products on offer provide the required quality? Since cannabis is to be sold in Germany as a pharmaceutical product, its production is regulated by the German Medicines Act and the Good Manufacturing Practice (GMP) guidelines. The guidelines aim to ensure the production of pharmaceutical products of consistent and high quality. However, product recalls in Canada are…
8. June 2022
General

Optimisation potential of the cannabis plant through sequencing

from von Rainer Krüger und Dr. Lisann Eßer, J&K Consulting The prescription of medicinal cannabis in Germany has been rising constantly in the last few years, which means that both the demand and the market are growing equally. However, medicinal cannabis is a drug whose active ingredient composition and concentration depend on the genetics of the plant and thus also achieve a different effect on the patient based on the genetics. By sequencing the genomes and comparing the sequences of…
8. June 2022
CannabisGeneral

Use of the Blockchain in the production of Medical Cannabis

from von Rainer Krüger, CEO, J&K Consulting This article describes how the production of medicinal cannabis can be optimised through the fully integrated use of blockchain technology in the manufacturing and transport processes, thus creating a continuous data and information network. It shows how blockchain can be applied in the regulatory challenging production of medicinal cannabis, increasing traceability and quality of the products. By applying digital technology along the entire value chain, the identity of the medicinal product can be…
8. June 2022
General

Digital development and production of medicinal cannabis

from von Rainer Krüger und Dr. Lisann Eßer, J&K Consulting Medicinal cannabis is being used more and more frequently as a form of therapy, which is why the demand in Germany is growing constantly. Producers are faced with the challenge not only of meeting the high demand, but also of ensuring the highest quality while complying with regulatory requirements. As in numerous economic sectors, digitalization is targeted as a solution to current and future problems by the cannabis industry. The…
19. February 2022
General

API Confusion and Lack of Regional Standards: Issues On The Road To The German Cannabis Market

from Marguerite Arnold Germany is the top target market for cannabis companies globally, but where your cultivator or distributor is located, especially in the realm of API standards, can make all the difference. Destination Germany is the watchword for those in the international cannabis industry—but it is still a rocky path to gaining access for most. Specifically, there is a lot of confusion surrounding API and cannabis classification and issues from a lack of consistent standards. One of the most intriguing aspects…
17. May 2021